DILTIAZEM TZ CAPSULE (EXTENDED RELEASE)

国家: 加拿大

语言: 英文

来源: Health Canada

现在购买

下载 产品特点 (SPC)
06-04-2021

有效成分:

DILTIAZEM HYDROCHLORIDE

可用日期:

PRO DOC LIMITEE

ATC代码:

C08DB01

INN(国际名称):

DILTIAZEM

剂量:

120MG

药物剂型:

CAPSULE (EXTENDED RELEASE)

组成:

DILTIAZEM HYDROCHLORIDE 120MG

给药途径:

ORAL

每包单位数:

100

处方类型:

Prescription

治疗领域:

MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS

產品總結:

Active ingredient group (AIG) number: 0115863004; AHFS:

授权状态:

CANCELLED POST MARKET

授权日期:

2021-07-27

产品特点

                                _Diltiazem TZ _
_Page 1 of 30 _
PRODUCT MONOGRAPH
PR
DILTIAZEM TZ
Diltiazem Hydrochloride
Extended-Release Capsules
120 mg, 180 mg, 240 mg, 300 mg and 360 mg
Manufacturer’s Standard
Antihypertensive/Antianginal Agent
PRO DOC LTÉE
Date of Revision:
2925, boul. Industriel
April 06, 2021
Laval, Québec
H7L 3W9
Submission Control No. 249784
_Diltiazem TZ _
_Page 2 of 30 _
PR
DILTIAZEM TZ
Diltiazem Hydrochloride
Extended-Release Capsules
120 mg, 180 mg, 240 mg, 300 mg and 360 mg
Antihypertensive/Antianginal Agent
ACTION AND CLINICAL PHARMACOLOGY
DILTIAZEM TZ (diltiazem hydrochloride) is a calcium ion cellular
influx inhibitor (calcium
entry blocker or calcium ion antagonist).
MECHANISM OF ACTION
The therapeutic effect of this group of drugs is believed to be
related to their specific cellular
action of selectively inhibiting transmembrane influx of calcium ions
into cardiac muscle and
vascular smooth muscle. The contractile processes of these tissues are
dependent upon the
movement of extracellular calcium into the cells through specific ion
channels. Diltiazem blocks
transmembrane influx of calcium through the slow channel without
affecting, to any significant
degree the transmembrane influx of sodium through the fast channel.
This results in a reduction
of free calcium ions available within cells of the above tissues.
Diltiazem does not alter total
serum calcium.
HYPERTENSION: The antihypertensive effect of diltiazem is believed to
be brought about largely
by its vasodilatory action on peripheral blood vessels with resultant
decrease in peripheral
vascular resistance.
ANGINA: The precise mechanism by which diltiazem relieves angina has
not been fully
determined, but it is believed to be brought about largely by its
vasodilatory action.
In angina of effort it appears that the action of diltiazem is related
to the reduction of myocardial
oxygen demand. This is probably caused by a decrease in blood pressure
brought about by the
reduction of peripheral resistance and of heart rate.
HEMODYNAMIC AND ELECTROPHYSIOLOGIC
                                
                                阅读完整的文件
                                
                            

其他语言的文件

产品特点 产品特点 法文 06-04-2021

搜索与此产品相关的警报